HANLON SUZANNE M. (Sec, VP & General Counsel) purchased 9.5% of their position (3.80K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $22.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/7/2018ACC: 0001192482-18-000385
Officer· Sec, VP & General Counsel
Since Aug 2018
+3.80K
Net shares
Net buyer
$22.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.80K
Price / share
$5.80
Trade value
$22.05K
% of position
9.5%
8/6/2018
39.89K→43.69K
Total
Net shares
+3.80K
Net value
$22.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2018 | P · Purchase | +3.80K | $5.80 | $22.05K | 9.5% | 39.89K | 43.69K |
| Total | +3.80K | $22.05K | ||||||
Derivative Transactions0
No derivative transactions reported